Dive into the dynamic world of Regulatory Affairs at Novo Nordisk.
Our team is devoted to gaining global approvals for our innovative medicines.
With a deep scientific understanding, a patient focus, and expertise in managing diverse stakeholder interests, every day with us is rewarding and intellectually enriching.
We are currently looking for Regulatory Affairs (RA) Specialist with a strong scientific background and a genuine interest in contributing to future developments within cardiometabolic and renal disease.
Apply now for this life-changing opportunity! The position As a Regulatory Affairs Lead for semaglutide cardiovascular outcome trial, you will be responsible for driving several regulatory tasks with challenging and often overlapping timelines.
Moreover, your interactions will span across project management, medical and non-clinical specialists, statisticians, and medical writers, and regional/local regulatory counterparts.
Your key responsibilities will include: • Collaborating closely with the Global Regulatory Lead to facilitate worldwide submissions and ensure successful approval, with a particular focus on type II variation submissions, Q& As, roll-out activities • Driving cross-functional teams to develop strategies and address inquiries from major Health Authorities, driving regulatory approval progress • Actively contributing to strategic project discussions, shaping regulatory strategies, challenging assumptions, and influencing critical business decisions.
• Contributing to initiatives aimed at optimising regulatory processes across the organization • Mentoring junior colleagues by sharing your expertise to support their professional development Our commitment to innovation also applies to the way we work.
We therefore embrace the hybrid workplace – with a blend of home office and on-site work in Soeborg, Denmark where the department is based.
Qualifications To succeed in this role, we expect you to have: • An academic degree such as master's degree and/or a Ph.
D.
within Life Science, Health Science or a related field coupled with a substantial and proven track record of relevant working experience • Solid practice with handling regulatory documentation for pharmaceutical development within the quality, non-clinical or clinical areas • Experience interacting directly with major health authorities on a global level (including FDA, EMA, PMDA, NMPA) • Strong negotiation skills and a sound understanding of business and data • Experience working within the diabetes or obesity areas is an advantage • Fluent written and spoken English As a person, you are well-organised and have solid problem-solving capabilities, just as you show a winning attitude and never lose your strategic focus.
You can keep your spirits high even when under pressure.
Your adept communication skills span across all levels of an organization.
You are proficient in providing guidance, leadership, and motivation, you adeptly steer your team towards shared objectives.
Simultaneously, you actively contribute as a collaborative team member, readily assisting your colleagues.
About the department RA Semaglutide is responsible for defining and driving regulatory strategies for our Semaglutide projects in all phases of development.
We are dedicated and highly engaged employees in the department belonging to the RA Semaglutide area.
We work as an integrated part of the global development and research projects and play a key role in cross-functional teams.
We are responsible for the Semaglutide regulatory strategy and provide regulatory expertise and tactics to product development plans.
We drive label development, health authority interactions and clinical trial applications.
We have a strong collaboration with our affiliates and global stakeholders in the regulatory teams.
Working at Novo Nordisk At Novo Nordisk, we don’t wait for change.
We drive it.
We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future.
We embrace the spirit of experimentation, striving for excellence without fixating on perfection.
We never shy away from opportunities to develop, we seize them.
From research and development, through to manufacturing, marketing, and sales – we’re all working to move the needle on patient care.
Contact For further information, please contact the Hiring Manager - Helene Nordahl at hecy@novonordisk.com.
Deadline 9th of February 2025. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV.
To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world.
We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures.
We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in.
Together, we’re life changing.
Reklame
Regulatory Affairs Lead - Cardiovascular Outcome Trials, Søborg
Free
Regulatory Affairs Lead - Cardiovascular Outcome Trials, Søborg
Denmark, Denmark, Søborg,
Udgivet February 4, 2025
Beskrivelse
Joboplysninger
⇐ Tidligere arbejde |
Næste job ⇒ |
Kontakt arbejdsgiver
Arbejdsgiver info

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 49,300 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com.
This page isn't intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk's office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industries. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here http://www.novonordisk.com/communityguidelines